News Center

Home page

Peak Report

News reports

Peak Pharmacy Launches Intangible Heritage Declaration

Release time:

2020-08-14

Peak Pharmacy Launches Intangible Cultural Heritage Application

News Recently, Peak Pharmacy Renshou Hall Traditional Chinese Medicine Culture Application List of Wucheng District Intangible Cultural Protection was officially launched and has officially submitted the intangible cultural heritage application form.

Renshou Hall existed during the Daoguang period of the Qing Dynasty. It is the oldest existing pharmacy in Jinhua City, the most complete preservation of its original features, and the only pharmacy listed as a key cultural relic protection unit in Jinhua City. By the end of the 11th century, Renshou Hall had a considerable scale and was the largest national pharmacy in Jinhua City.

Since the founding of Renshou Hall, the shopkeeper has regarded "benevolence and righteousness as the foundation, longevity as the first" as the criterion, advocating medical ethics and emphasizing medical ethics, so it has a good reputation and a long-term reputation. The main way of its business is to ensure the quality of medicines. The purchase of medicinal materials "is not afraid of high prices, but it is authentic", and it is very particular about the time of purchase. Some precious and rare medicinal materials, pharmacies will send special personnel to the place of origin to buy. Renshou Hall also has deer breeding garden. There are more than 16 kinds of proprietary Chinese medicines

240# such as self-made donkey skin ointment, ginseng re-engineering pills, purple snow Dan, Zijin ingot marching powder, Babao eye medicine, etc. Due to its real price and unique curative effect, the proprietary medicines sold have become the first choice of famous doctors, selling well in gold, Qu and Yan, affecting Fujian, Jiangxi and other provinces. "Strictly governing the store to benefit the world" is another criterion of Renshou Hall, and it is also the guarantee of drug quality and service quality. The apprentice entered the door and learned how to put the medicine in the bucket until he learned to check the quality of the medicinal materials and concoct the medicinal materials. After at least three years and strict examination, he could sell the medicine on the counter after passing the strict examination. After work, all shop assistants should read and learn Chinese characters to improve their cultural quality.

1956

, Renshou Hall was a public-private partnership and merged into a pharmaceutical company under the Jinhua County Bureau of Commerce at that time. Its operating efficiency has always been among the best in pharmacies in Jinhua city, maintaining a rigorous store management system and drug quality. At present, Renshou Hall is a chain store owned by Jianfeng Pharmacy. In July,

, 2012, , , , it successfully passed the evaluation of Jinhua Municipal Bureau of Commerce and became the first batch of "Jinhua Time-honored Brands". 2016 was named the second batch of Zhejiang gold medal time-honored enterprises (brands), and Jinhua is the only enterprise (brand) to receive this honor. In order to inherit the ancient traditional Chinese medicine culture and carry forward the fine tradition of the century-old shop, Jianfeng Pharmacy has declared the list of intangible culture protection in Wucheng District with the traditional Chinese medicine culture of Renshoutang.

In addition, in order to further do a good job in the application, the pharmacy also sent commissioners to attend the

2018

intangible cultural heritage (traditional diet, traditional medicine) training courses held in Jinhua on 12 July 4 and 5 , let the trainees have a better understanding of the application of intangible cultural heritage projects and the current situation and protection of the intangible cultural heritage of traditional medicine in Zhejiang Province, and prepare for the follow-up application of the municipal intangible cultural heritage of Renshoutang traditional Chinese medicine culture in Jianfeng Pharmacy. (Zhang Yueshun Ni Yingzhen)

More information

Monitoring Report of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project

2020

07-30

Monitoring Report of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project

2020

07-31

Monitoring Report of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project

2020

07-31

Daye Jianfeng Cement Co., Ltd. Kiln End Flue Gas Desulfurization Project Completion Environmental Protection Acceptance Publicity

Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution

2020

07-31

Spike New Drug Approved for Registration

On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)

2020

07-31

Spike New Drug Approved for Registration

2020

07-31

< 1...30 31 32...61 > 跳转到页